(Q33836224)

English

Functional brain imaging in the resting state and during activation in Alzheimer's disease. Implications for disease mechanisms involving oxidative phosphorylation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 July 2017

Functional brain imaging in the resting state and during activation in Alzheimer's disease. Implications for disease mechanisms involving oxidative phosphorylation (English)

1 reference

Europe PubMed Central

29 July 2017

Alzheimer's disease

0 references

phosphorylation

1 reference

based on heuristic

inferred from title

Stanley I. Rapoport

1

object named as

Rapoport SI

1 reference

Europe PubMed Central

29 July 2017

language of work or name

0 references

publication date

1 January 1999

1 reference

Europe PubMed Central

29 July 2017

number of pages

16

1 reference

based on heuristic

inferred from page(s)

Annals of the New York Academy of Sciences

1 reference

Europe PubMed Central

29 July 2017

893

1 reference

Europe PubMed Central

29 July 2017

138-153

1 reference

Europe PubMed Central

29 July 2017

Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07823.X

21 January 2018

Intercorrelations of regional cerebral glucose metabolic rates in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07823.X

21 January 2018

Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer's-type dementia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07823.X

21 January 2018

Longitudinal study of the early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer type.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07823.X

21 January 2018

Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07823.X

21 January 2018

Regional specificity of membrane instability in Alzheimer's disease brain.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07823.X

21 January 2018

Membrane phospholipid alterations in Alzheimer's disease: deficiency of ethanolamine plasmalogens

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07823.X

21 January 2018

The FDG/PET methodology for early detection of disease onset: a statistical model

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07823.X

21 January 2018

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07823.X

21 January 2018

Early detection of Alzheimer's disease: a statistical approach using positron emission tomographic data

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07823.X

21 January 2018

Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07823.X

21 January 2018

Activation of cerebral blood flow during a visuoperceptual task in patients with Alzheimer-type dementia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07823.X

21 January 2018

Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07823.X

21 January 2018

Parametric analysis of functional neuroimages: application to a variable-rate motor task.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07823.X

21 January 2018

Visual cortical dysfunction in Alzheimer's disease evaluated with a temporally graded "stress test" during PET.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07823.X

21 January 2018

Stimulus rate determines regional brain blood flow in striate cortex.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07823.X

21 January 2018

Neuronal activity and early neurofibrillary tangles in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07823.X

21 January 2018

Gene expression of ND4, a subunit of complex I of oxidative phosphorylation in mitochondria, is decreased in temporal cortex of brains of Alzheimer's disease patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07823.X

21 January 2018

Evidence for physiological down-regulation of brain oxidative phosphorylation in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07823.X

21 January 2018

Brain energy metabolism, cognitive function and down-regulated oxidative phosphorylation in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07823.X

21 January 2018

Decreased expression of nuclear and mitochondrial DNA-encoded genes of oxidative phosphorylation in association neocortex in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07823.X

21 January 2018

Cytochrome oxidase: an endogenous metabolic marker for neuronal activity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07823.X

21 January 2018

Localization of cytochrome oxidase (COX) activity and COX mRNA in the hippocampus and entorhinal cortex of the monkey brain: correlation with specific neuronal pathways.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07823.X

21 January 2018

Localization of cytochrome oxidase (COX) activity and COX mRNA in the perirhinal and superior temporal sulci of the monkey brain.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07823.X

21 January 2018

Mitochondrial function in brain tissue in primary degenerative dementia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07823.X

21 January 2018

The machinery of mitochondrial inheritance and behavior

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07823.X

21 January 2018

Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07823.X

21 January 2018

No association between Alzheimer plaques and decreased levels of cytochrome oxidase subunit mRNA, a marker of neuronal energy metabolism.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07823.X

21 January 2018

Quantitative assessment of cortical synaptic density in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07823.X

21 January 2018

Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07823.X

21 January 2018

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07823.X

21 January 2018

Mitochondrial diseases in man and mouse

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07823.X

21 January 2018

Coordination of ATP production and consumption in brain: parallel regulation of cytochrome oxidase and Na+, K(+)-ATPase

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07823.X

21 January 2018

Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07823.X

21 January 2018

Alpha-ketoglutarate dehydrogenase in Alzheimer brains bearing the APP670/671 mutation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07823.X

21 January 2018

Mitochondrial dysfunction in neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07823.X

21 January 2018

Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07823.X

21 January 2018

Electron transport chain defects in Alzheimer's disease brain.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07823.X

21 January 2018

Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07823.X

21 January 2018

Frequency Variation of a Pattern-Flash Visual Stimulus during PET Differentially Activates Brain from Striate through Frontal Cortex

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB07823.X

21 January 2018

Identifiers

10.1111/J.1749-6632.1999.TB07823.X

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33836224&oldid=1772307572"